```
REGISTERED CHARITY NUMBER: 1010090
```

## **`REPORT OF THE TRUSTEES AND`** 

```
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 5TH APRIL 2021
```

## **`FOR`** 

## **`CLINICAL RESEARCH TRUST`** 

```
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```



```
CLINICAL RESEARCH TRUST
```

```
CONTENTS OF THE FINANCIAL STATEMENTS
for the year ended 5th April 2021
```

||**`Page`**|
|---|---|
|**`Report of the Trustees`**|`1 to 2`|
|**`Independent Examiner's Report`**|`3`|
|**`Statement of Financial Activities`**|`4`|
|**`Balance Sheet`**|`5`|
|**`Notes to the Financial Statements`**|`6 to 10`|
|**`Detailed Statement of Financial Activities`**|`11`|





```
CLINICAL RESEARCH TRUST
```

## **`REPORT OF THE TRUSTEES for the year ended 5th April 2021`** 

```
Thetrusteespresenttheirreportwiththefinancialstatementsofthecharityfortheyear ended
5thApril2021.ThetrusteeshaveadoptedtheprovisionsofAccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordance with
the FinancialReportingStandardapplicablein the UK and Republicof Ireland(FRS 102)(effective1  January
2019).
```

## **`OBJECTIVES AND ACTIVITIES`** 

## **`Objectives and aims`** 

```
TheobjectivesoftheTrustisthepromotionofClinicalandFundamentalResearchintothecauses and
treatment of clinical diseases on terms that the results of such research are published..
```

## **`Current activities`** 

```
The ClinicalResearchTrusthas movedits supportto the workundertakenby the NorwichMedical School
intheUniversityofEastAnglia.Theresearchhasfocusedonworktoimprovetheknowledgeof the
pathogenesisofthecondition,characterisationoftoxicepitopesinwheatandmethodtomeasure these
cereals in foods to individuals with coeliac disease.
```

```
The Trust continuesto improvethe treatmentand providea betterunderstandingof the conditionand the
pathogenesistohelpthe670,000affectedsubjectsintheUK,includingchildrenandmillions more
worldwide to improve not only their treatment, but also to improve their quality of life.
```

## **`FINANCIAL REVIEW`** 

## **`Reserves policy`** 

```
The Trust maintains a reserve sufficient to meet its annual demands.
```

## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`** 

## **`Governing document`** 

```
Thecharityiscontrolledbyitsgoverningdocument,adeedoftrustandconstitutesan unincorporated
charity.
```

## **`Risk management`** 

```
Thetrusteeshaveadutytoidentifyandreviewtheriskstowhichthecharityisexposedandto ensure
appropriate controls are in place to provide reasonable assurance against fraud and error.
```

## **`REFERENCE AND ADMINISTRATIVE DETAILS`** 

## **`Registered Charity number`** 

```
1010090
```

## **`Principal address`** 

```
25 Penzance Street
Holland Park
London
W11 4QX
```

```
Page 1
```



```
CLINICAL RESEARCH TRUST
```

## **`REPORT OF THE TRUSTEES`** 

```
for the year ended 5th April 2021
```

## **`Trustees`** 

```
Professor E K Sikora
Professor P J Ciclitira
```

## **`Independent Examiner`** 

```
Miss Katharine Jones
ACA
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```

```
Approved by order of the board of trustees on 24th January 2022 and signed on its behalf by:
```

```
Professor P J Ciclitira - Trustee
```

```
Page 2
```



```
INDEPENDENT EXAMINER'S REPORT TO THE TRUSTEES OF
CLINICAL RESEARCH TRUST
```

## **`Independent examiner's report to the trustees of Clinical Research Trust`** 

```
I reportto the charitytrusteeson my examinationof the accountsof ClinicalResearchTrust(the Trust) for
the year ended 5th April 2021.
```

## **`Responsibilities and basis of report`** 

```
AsthecharitytrusteesoftheTrustyouareresponsibleforthepreparationoftheaccountsin accordance
with the requirements of the Charities Act 2011 ('the Act').
```

```
I reportin respectofmyexaminationoftheTrust'saccountscarriedoutundersection145oftheAct and
incarryingoutmyexaminationIhavefollowedallapplicableDirectionsgivenbytheCharity Commission
under section 145(5)(b) of the Act.
```

## **`Independent examiner's statement`** 

```
Ihavecompletedmyexamination.Iconfirmthatnomaterialmattershavecometomyattention in
connection with the examination giving me cause to believe that in any material respect:
```

`1. accounting records were not kept in respect of the Trust as required by section 130 of the Act; or` 

`2. the accounts do not accord with those records; or` 

`3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.` 

```
Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationto which
attentionshouldbedrawninthisreportinordertoenableaproperunderstandingoftheaccountsto be
reached.
```

```
Miss Katharine Jones
ACA
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```

```
24th January 2022
```

```
Page 3
```



## **`CLINICAL RESEARCH TRUST`** 

## **`STATEMENT OF FINANCIAL ACTIVITIES`** 

## **`for the year ended 5th April 2021`** 

|**`2021`**<br>**`Unrestricted`**<br>**`fund`**<br>`Notes`<br>**`£`**<br>**`INCOME AND ENDOWMENTS FROM`**<br>`Donations and legacies`<br>**`50,377`**<br>**`EXPENDITURE ON`**<br>**`Charitable activities`**<br>`Grants`<br>**`49,540`**<br>`Other`<br>**`873`**<br>**`Total`**<br>**`50,413`**<br>**`NET INCOME/(EXPENDITURE)`**<br>**`(36)`**<br>**`RECONCILIATION OF FUNDS`**<br>**`Total funds brought forward`**<br>**`1,383`**<br>**`TOTAL FUNDS CARRIED FORWARD`**<br>**`1,347`**|`2020`<br>`Total`<br>`funds`<br>`£`<br>`56,634`<br>`56,145`<br>`860`<br>`57,005`<br>`(371)`<br>`1,754`<br>`1,383`|
|---|---|



```
The notes form part of these financial statements
```

```
Page 4
```



## **`CLINICAL RESEARCH TRUST`** 

## **`BALANCE SHEET`** 

## **`5th April 2021`** 

|||**`2021`**|`2020`|
|---|---|---|---|
|||**`Unrestricted`**|`Total`|
|||**`fund`**|`funds`|
||`Notes`|**`£`**|`£`|
|**`FIXED ASSETS`**||||
|`Investments`|`4`|**`2,160`**|`2,160`|
|**`CURRENT ASSETS`**||||
|`Cash at bank`||**`891`**|`903`|
|**`CREDITORS`**||||
|`Amounts falling due within one year`|`5`|**`(1,704)`**|`(1,680)`|
|**`NET CURRENT ASSETS`**||**`(813)`**|`(777)`|
|**`TOTAL ASSETS LESS CURRENT LIABILITIES`**||**`1,347`**|`1,383`|
|**`NET ASSETS`**||**`1,347`**|`1,383`|
|**`FUNDS`**|`6`|||
|`Unrestricted funds`||**`1,347`**|`1,383`|
|**`TOTAL FUNDS`**||**`1,347`**|`1,383`|



```
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on
24th January 2022 and were signed on its behalf by:
```

```
P J Ciclitira - Trustee
```

```
The notes form part of these financial statements
```

```
Page 5
```



```
CLINICAL RESEARCH TRUST
```

```
NOTES TO THE FINANCIAL STATEMENTS
for the year ended 5th April 2021
```

## **`1. ACCOUNTING POLICIES`** 

## **`Basis of preparing the financial statements`** 

```
Thefinancialstatementsofthecharity,whichisapublicbenefitentityunderFRS102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsin accordance
withtheFinancialReportingStandardapplicableintheUKandRepublicofIreland(FRS 102)
(effective1January2019)',FinancialReportingStandard102'TheFinancialReporting Standard
applicableintheUKandRepublicofIreland'andtheCharitiesAct2011.Thefinancial statements
havebeenpreparedunderthehistoricalcostconvention,withtheexceptionofinvestments which
are included at market value.
```

## **`Financial reporting standard 102 - reduced disclosure exemptions`** 

```
Thecharityhastakenadvantageofthefollowingdisclosureexemptionsin preparingthese financial
statements,aspermittedbyFRS102'TheFinancialReportingStandardapplicableintheUK and
Republic of Ireland':
```

- `the requirements of Section 7 Statement of Cash Flows.` 

## **`Income`** 

```
Allincomeis recognisedin theStatementofFinancialActivitiesoncethecharityhasentitlement to
the funds, it is probable that the income will be received and the amount can be measured reliably.
```

## **`Expenditure`** 

```
Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructive obligation
committingthe charityto that expenditure,it is probablethat a transferof economicbenefitswill be
requiredinsettlementandtheamountoftheobligationcanbemeasuredreliably.Expenditure is
accountedforonanaccrualsbasisandhasbeenclassifiedunderheadingsthataggregateall cost
relatedtothecategory.Wherecostscannotbedirectlyattributedtoparticularheadingsthey have
been allocated to activities on a basis consistent with the use of resources.
```

```
Grantsofferedsubjecttoconditionswhichhavenotbeenmetattheyearenddatearenotedas a
commitment but not accrued as expenditure.
```

## **`Taxation`** 

```
The charity is exempt from tax on its charitable activities.
```

## **`Fund accounting`** 

```
Unrestrictedfundscanbe usedin accordancewiththecharitableobjectivesat thediscretionof the
trustees.
```

```
Restrictedfunds can only be used for particularrestrictedpurposeswithin the objectsof the  charity.
Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted
purposes.
```

```
Furtherexplanationofthenatureandpurposeofeachfundis includedin thenotestothe financial
statements.
```

```
continued...
```

```
Page 6
```



```
CLINICAL RESEARCH TRUST
```

```
NOTES TO THE FINANCIAL STATEMENTS - continued
```

```
for the year ended 5th April 2021
```

## **`2. TRUSTEES' REMUNERATION AND BENEFITS`** 

```
Therewerenotrustees'remunerationorotherbenefitsfortheyearended5thApril2021nor for
the year ended 5th April 2020.
```

## **`Trustees' expenses`** 

```
Therewerenotrustees'expensespaidfortheyearended5thApril2021norfortheyear ended
5th April 2020.
```

## **`3. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`** 

||`Unrestricte`|
|---|---|
||`fund`|
||`£`|
|**`INCOME AND ENDOWMENTS FROM`**||
|`Donations and legacies`|`56,634`|
|**`EXPENDITURE ON`**||
|**`Charitable activities`**||
|`Grants`|`56,145`|
|`Other`|`860`|
|**`Total`**|`57,005`|
|**`NET INCOME/(EXPENDITURE)`**|`(371)`|
|**`RECONCILIATION OF FUNDS`**||
|**`Total funds brought forward`**|`1,754`|
|**`TOTAL FUNDS CARRIED FORWARD`**|`1,383`|



```
continued...
```

```
Page 7
```



```
CLINICAL RESEARCH TRUST
```

## **`NOTES TO THE FINANCIAL STATEMENTS - continued`** 

## **`for the year ended 5th April 2021`** 

## **`4. FIXED ASSET INVESTMENTS`** 

||`Listed`|
|---|---|
||`investment`|
||`£`|
|**`MARKET VALUE`**||
|`At 6th April 2020 and 5th April 2021`|**`2,160`**|
|**`NET BOOK VALUE`**||
|`At 5th April 2021`|**`2,160`**|
|`At 5th April 2020`|`2,160`|
|`There were no investment assets outside the UK.`||



## **`5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`** 

|`Trade creditors`<br>`Other creditors`|**`2021`**<br>**`£`**<br>**`840`**<br>**`864`**<br>**`1,704`**|`2020`<br>`£`<br>`840`<br>`840`|
|---|---|---|
|||`1,680`|



## **`6. MOVEMENT IN FUNDS`** 

|**`MOVEMENT IN FUNDS`**||||
|---|---|---|---|
|||`Net`||
|||`movement`|`At`|
||`At 6/4/20`|`in funds`|`5/4/21`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|**`1,383`**|**`(36)`**|**`1,347`**|
|**`TOTAL FUNDS`**|**`1,383`**|**`(36)`**|**`1,347`**|
|`Net movement in funds, included in the above are as follows:`||||
||`Incoming`|`Resources`|`Movement`|
||`resources`|`expended`|`in funds`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|**`50,377`**|**`(50,413)`**|**`(36)`**|
|**`TOTAL FUNDS`**|**`50,377`**|**`(50,413)`**|**`(36)`**|



```
continued...
```

```
Page 8
```



```
CLINICAL RESEARCH TRUST
```

```
NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 5th April 2021
```

## **`6. MOVEMENT IN FUNDS - continued`** 

## **`Comparatives for movement in funds`** 

|||`Net`||
|---|---|---|---|
|||`movement`|`At`|
||`At 6/4/19`|`in funds`|`5/4/20`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`1,754`|`(371)`|`1,383`|
|**`TOTAL FUNDS`**|`1,754`|`(371)`|`1,383`|
|`Comparative net movement in funds, included in the above are as follows:`||||
||`Incoming`|`Resources`|`Movement`|
||`resources`|`expended`|`in funds`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`56,634`|`(57,005)`|`(371)`|
|**`TOTAL FUNDS`**|`56,634`|`(57,005)`|`(371)`|



```
A current year 12 months and prior year 12 months combined position is as follows:
```

|||`Net`||
|---|---|---|---|
|||`movement`|`At`|
||`At 6/4/19`|`in funds`|`5/4/21`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`1,754`|`(407)`|`1,347`|
|**`TOTAL FUNDS`**|`1,754`|`(407)`|`1,347`|



```
continued...
```

```
Page 9
```



```
CLINICAL RESEARCH TRUST
```

```
NOTES TO THE FINANCIAL STATEMENTS - continued
for the year ended 5th April 2021
```

## **`6. MOVEMENT IN FUNDS - continued`** 

```
Acurrentyear12monthsandprioryear12monthscombinednetmovementinfunds,included in
the above are as follows:
```

||`Incoming`|`Resources`|`Movement`|
|---|---|---|---|
||`resources`|`expended`|`in funds`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`107,011`|`(107,418)`|`(407)`|
|**`TOTAL FUNDS`**|`107,011`|`(107,418)`|`(407)`|



## **`7. RELATED PARTY DISCLOSURES`** 

```
There were no related party transactions for the year ended 5th April 2021.
```

```
Page 10
```



```
CLINICAL RESEARCH TRUST
```

## **`DETAILED STATEMENT OF FINANCIAL ACTIVITIES`** 

## **`for the year ended 5th April 2021`** 

|**`INCOME AND ENDOWMENTS`**<br>**`Donations and legacies`**<br>`Donations`<br>**`Total incoming resources`**<br>**`EXPENDITURE`**<br>**`Charitable activities`**<br>`Grants to institutions`<br>**`Support costs`**<br>**`Finance`**<br>`Bank charges`<br>**`Governance costs`**<br>`Accountancy`<br>`Total resources expended`<br>**`Net expenditure`**|`2021`<br>`£`<br>**`50,377`**<br>**`50,377`**<br>**`49,540`**<br>**`-`**<br>**`873`**<br>**`50,413`**<br>**`(36)`**|`2020`<br>`£`<br>`56,634`<br>`56,634`<br>`56,145`<br>`20`<br>`840`<br>`57,005`<br>`(371)`|
|---|---|---|



```
This page does not form part of the statutory financial statements
```

```
Page 11
```